These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20051112)

  • 1. Serum levels of soluble Fas, soluble tumor necrosis factor-receptor II, interleukin-2 receptor and interleukin-8 as early predictors of hepatocellular carcinoma in Egyptian patients with hepatitis C virus genotype-4.
    Zekri AR; Alam El-Din HM; Bahnassy AA; Zayed NA; Mohamed WS; El-Masry SH; Gouda SK; Esmat G
    Comp Hepatol; 2010 Jan; 9(1):1. PubMed ID: 20051112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Serum Level of Soluble Tumor Necrosis Factor Receptor IIα in Egyptian Patients With Chronic Hepatitis C Virus Infection and Hepatocellular Carcinoma.
    Fouad SA; Elsaaid NH; Mohamed NA; Abutaleb OM
    Hepat Mon; 2014 Sep; 14(9):e19346. PubMed ID: 25386197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulators, sFas and Fas-L as potential noninvasive predictors of IFN treatment in patients with HCV genotype-4.
    Zekri AR; Haleem HA; Esmat GE; Bahnassy AA; El-Din HM; Hafez MM; Sharaby AF; Sharaf H; Zakaria MS
    J Viral Hepat; 2007 Jul; 14(7):468-77. PubMed ID: 17576388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression.
    Zekri AR; Ashour MS; Hassan A; Alam El-Din HM; El-Shehaby AM; Abu-Shady MA
    World J Gastroenterol; 2005 Nov; 11(42):6624-30. PubMed ID: 16425355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
    Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
    Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study.
    Huang YS; Hwang SJ; Chan CY; Wu JC; Chao Y; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):327-33. PubMed ID: 10389289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal liver injury in chronic hepatitis C virus infection is associated with low levels of soluble TNF-alpha/Fas receptors and acquisition in childhood.
    Macías J; Sánchez-Quijano A; Pineda JA; Abad MA; Rubio A; Rosa R; Leal M; Lissen E
    Liver; 2001 Dec; 21(6):410-4. PubMed ID: 11903886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Serum Soluble Fibrinogen-Like Protein 2 with Soluble FAS Ligand and Interferon Gamma in Egyptian Hepatitis C Virus-Infected Patients and Hepatocellular Carcinoma Patients.
    El-Mesery M; El-Mowafy M; Elgaml A; Youssef LF; Abed SY
    J Interferon Cytokine Res; 2017 Aug; 37(8):342-347. PubMed ID: 28609212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
    Motawi TK; Shaker OG; Ismail MF; Sayed NH
    Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High tumor necrosis factor-α/interleukin-10 ratio is associated with hepatocellular carcinoma in patients with chronic hepatitis C.
    Aroucha DC; do Carmo RF; Moura P; Silva JL; Vasconcelos LR; Cavalcanti MS; Muniz MT; Aroucha ML; Siqueira ER; Cahú GG; Pereira LM; Coêlho MR
    Cytokine; 2013 Jun; 62(3):421-5. PubMed ID: 23602201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma.
    Jodo S; Kobayashi S; Nakajima Y; Matsunaga T; Nakayama N; Ogura N; Kayagaki N; Okumura K; Koike T
    Clin Exp Immunol; 1998 May; 112(2):166-71. PubMed ID: 9649177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of interleukin IL-6 rs-1474347 and IL-10 rs-1800896 genetic polymorphisms on the susceptibility of HCV-infected Egyptian patients to hepatocellular carcinoma.
    Abd El-Baky RM; Hetta HF; Koneru G; Ammar M; Shafik EA; Mohareb DA; Abbas El-Masry M; Ramadan HK; Abu Rahma MZ; Fawzy MA; Fathy M
    Immunol Res; 2020 Jun; 68(3):118-125. PubMed ID: 32504406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating and hepatic Fas expression in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El Bassiouny AE; El-Bassiouni NE; Nosseir MM; Zoheiry MM; El-Ahwany EG; Salah F; Omran ZS; Ibrahim RA
    Medscape J Med; 2008 Jun; 10(6):130. PubMed ID: 18679533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.
    Izzo F; Cremona F; Delrio P; Leonardi E; Castello G; Pignata S; Daniele B; Curley SA
    Ann Surg Oncol; 1999 Mar; 6(2):178-85. PubMed ID: 10082044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Beta-2 Microglobulin: a Possible Marker for Disease Progression in Egyptian Patients with Chronic HCV Related Liver Diseases.
    Ouda SM; Khairy AM; Sorour AE; Mikhail MN
    Asian Pac J Cancer Prev; 2015; 16(17):7825-9. PubMed ID: 26625805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of tumor necrosis factor receptors 1 and 2 in chronic hepatitis B and C: the differences and implications in pathogenesis.
    Tai DI; Tsai SL; Chen TC; Lo SK; Chang YH; Liaw YF
    J Biomed Sci; 2001; 8(4):321-7. PubMed ID: 11455194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.